0001209191-23-023683.txt : 20230406
0001209191-23-023683.hdr.sgml : 20230406
20230406203630
ACCESSION NUMBER: 0001209191-23-023683
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230404
FILED AS OF DATE: 20230406
DATE AS OF CHANGE: 20230406
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: D'Angio Paul
CENTRAL INDEX KEY: 0001843748
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40045
FILM NUMBER: 23807574
MAIL ADDRESS:
STREET 1: C/O NEXIMMUNE, INC.
STREET 2: 9119 GAITHER ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20877
FORMER NAME:
FORMER CONFORMED NAME: D''Angio Paul
DATE OF NAME CHANGE: 20210201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NexImmune, Inc.
CENTRAL INDEX KEY: 0001538210
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9119 GAITHER ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 301-825-9810
MAIL ADDRESS:
STREET 1: 9119 GAITHER ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-04
0
0001538210
NexImmune, Inc.
NEXI
0001843748
D'Angio Paul
C/O NEXIMMUNE, INC.
9119 GAITHER ROAD
GAITHERSBURG
MD
20877
1
0
0
0
0
Stock Option (right to buy)
1.82
2023-04-04
4
D
0
61678
D
2032-06-12
Common Stock
61678
0
D
Stock Option (right to buy)
1.64
2023-04-04
4
A
0
61678
A
2032-06-12
Common Stock
61678
61678
D
Stock Option (right to buy)
17.00
2023-04-04
4
D
0
9556
D
2031-02-10
Common Stock
9556
0
D
Stock Option (right to buy)
1.64
2023-04-04
4
A
0
9556
A
2031-02-10
Common Stock
9556
9556
D
Stock Option (right to buy)
4.31
2023-04-04
4
D
0
23122
D
2029-03-18
Common Stock
23122
0
D
Stock Option (right to buy)
1.64
2023-04-04
4
A
0
23122
A
2029-03-18
Common Stock
23122
23122
D
Stock Option (right to buy)
2.42
2023-04-04
4
D
0
12634
D
2037-03-02
Common Stock
12634
0
D
Stock Option (right to buy)
1.64
2023-04-04
4
A
0
12634
A
2037-03-02
Common Stock
12634
12634
D
The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. D'Angio's continued service on such vesting date.
The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested.
The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 19, 2019, of which all of the shares subject to such option have vested.
The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 3, 2017, of which all of the shares subject to such option have vested.
/s/ John Rudy, attorney-in-fact
2023-04-06